Drugs / AM001
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03210740 | Jun 2017 → Feb 2018 | actinic keratosis | AmDerma | Completed | No outcome recorded |
| Phase 2 | NCT03005964 | Dec 2016 → Aug 2017 | psoriasis | AmDerma | Completed | No outcome recorded |
| Phase 2 | NCT01938599 | Aug 2013 → May 2014 | erythematosquamous dermatosis, psoriasis | AmDerma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AM001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01938599 ↗ |